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Background: We recently described a novel autosomal recessive neurodevelopmental disorder with intellectual
disability in four patients from two related Hutterite families. Identity-by-descent mapping localized the gene to a
5.1 Mb region at chromosome 16p13.3 containing more than 170 known or predicted genes. The objective of this
study was to identify the causative gene for this rare disorder.
Methods and results: Candidate gene sequencing followed by exome sequencing identified a homozygous
missense mutation p.Gly46Arg, in THOC6. No other potentially causative coding variants were present within the
critical region on chromosome 16. THOC6 is a member of the THO/TREX complex which is involved in coordinating
mRNA processing with mRNA export from the nucleus. In situ hybridization showed that thoc6 is highly expressed
in the midbrain and eyes. Cellular localization studies demonstrated that wild-type THOC6 is present within the
nucleus as is the case for other THO complex proteins. However, mutant THOC6 was predominantly localized to
the cytoplasm, suggesting that the mutant protein is unable to carry out its normal function. siRNA knockdown of
THOC6 revealed increased apoptosis in cultured cells.
Conclusion: Our findings associate a missense mutation in THOC6 with intellectual disability, suggesting the THO/
TREX complex plays an important role in neurodevelopment.
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Intellectual disability (ID) is the most frequent handicap
affecting children and it is one of the greatest challenges
in healthcare as ID is associated with life-long impair-
ments that have a profound impact on individuals, fam-
ilies, and society. Genetic causes of ID are diverse and
include chromosomal aberrations and autosomal domin-
ant, X-linked, autosomal recessive, and mitochondrial
DNA mutations. Nonsyndromic ID is characterized by ID
as the sole clinical feature in patients, while syndromic ID
occurs in combination with one or more additional clin-
ical features. Recently, next-generation sequencing of 136
consanguineous families identified 23 previously impli-
cated ID genes and 50 novel candidate genes, confirming* Correspondence: kboycott@cheo.on.ca
†Equal contributors
1Children’s Hospital of Eastern Ontario Research Institute, University of
Ottawa, 401 Smyth Road, Ottawa, ON K1H 8L1, Canada
Full list of author information is available at the end of the article
© 2013 Beaulieu et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orthe suspected significant genetic heterogeneity underlying
ID [1].
The Hutterites are a German-speaking Anabaptist
group that arose during the Protestant Reformation
(1528) in South Tyrol (Austria) [2]. The Hutterite popu-
lation has been living on the North American prairies
since the late 1800s, now numbers over 40,000, and is
comprised of three essentially endogamous groups,
Schmiedeleut, Dariusleut, and Lehrerleut. Their genetic
isolation, small founder population, excellent genea-
logical records, large completed family size, and uptake
of modern health care facilitates genetic studies [2].
Over 30 autosomal recessive conditions have been iden-
tified within this population and additional novel Men-
delian disorders continue to be recognized [3].
We recently described a novel autosomal recessive ID
disorder in two sets of sisters from related Dariusleut
Hutterite families [4]. As previously described, theirl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and head circumference at the 2nd centile without ap-
parent structural CNS malformations on MRI. All four
patients share recognizable facial features including a tall
forehead with high anterior hairline, deeply-set eyes with
short, upslanting palpebral fissures, long nose with low-
hanging columella, and thick vermilion of the upper and
lower lip. Other clinical features include dental mal-
occlusion and caries, myopia, malformations of the heart
(one patient with patent ductus arteriosus and ventricu-
lar septal defect, another with ventricular septal defect
only), and renal abnormalities (one patient with horse-
shoe kidney, another patient with left renal agenesis and
renal failure identified at age 13 requiring dialysis
followed by transplant at age 15 years; at diagnosis the
unilateral right kidney was echogenic and atrophic on
ultrasound imaging) [4]. The patients underwent neuro-
psychological testing to further characterize their learn-
ing disabilities and the results were consistent with
moderate ID without a significant difference between
verbal comprehension and perceptual reasoning. Based
on the clinical presentation, this disorder is best classi-
fied as a syndromic form of ID, but due to the subtle
and variable nature of the additional features the diagno-
sis of syndromic ID could be easily missed. Furthermore,
the distinction between syndromic and nonsyndromic is
becoming blurred with a subset of ID genes causing
both forms of disability [5,6].
A single region on 16p13.3 was identified by genome-
wide homozygosity mapping with DNA samples from
the four patients using a 50K Affymetrix GeneChip SNP
array followed by refinement with microsatellite markers
using all available family members [4]. The maximum
size of the region was 5.1 Mb with the distal boundary at
1,404,019 and the proximal boundary at 6,458,669 (NCBI
Build 36.3) [4]. Sanger followed by exome sequencing iden-
tified a single potential disease-causing missense mutation
in THOC6 (fSAP35; WDR58). THOC6 is a part of the THO
complex which is involved in coordinating mRNA process-
ing with export. We demonstrate that the p.Gly46Arg sub-
stitution results in protein mislocalization to the cytoplasm
suggesting that the mutant protein is unable to carry out an
export function. Moreover, depletion of THOC6 induces
apoptosis in mammalian cells. These findings indicate that
the THOC6 missense mutation perturbs protein function,
supporting a disease-association between THOC6 and
intellectual disability and an important role for the THO/
TREX complex in neurodevelopment.
Methods
Patient recruitment
Institutional Research Ethics Board approval for the
study reported here was obtained from the University of
Calgary and the Children’s Hospital of Eastern Ontarioand informed consent was obtained from responsible
persons (parents) on behalf of all study participants.
Total genomic DNA was extracted from blood following
standard procedures.Sanger sequencing
Ninety-seven out of the 173 genes within the 5.1 Mb critical
region on 16p13.3 (NCBI build 36.3, including hypothetical
genes and pseudogenes) were PCR amplified and Sanger se-
quenced. These genes were chosen based on expression or
function indicating a potential role in neurodevelopment;
genes associated with dissimilar disorders or unrelated
functions were excluded from sequencing. Primers were
designed to assess the coding regions and intron-exon
boundaries of the prioritized genes using the program Oligo
(Molecular Biology Insights, Inc., Cascade, CO). PCR and
bidirectional sequencing was performed on DNA samples
from a patient, a parent, and unaffected control. Primer se-
quences and reaction conditions are available upon request.
Sequence subtraction analysis was performed using Muta-
tion Surveyor (SoftGenetics LLC, State College, PA).Exome sequencing
Exome capture and high-throughput sequencing of DNA
from one patient was performed at the McGill University
and Genome Québec Innovation Centre (Montréal,
Canada). Exome target enrichment was performed using
the Agilent SureSelect 50 Mb All Exon Kit (V3), and se-
quencing (Illumina HiSeq) generated 14 Gbp of 100 bp
paired-end reads. An in-house annotation pipeline was
used to call and annotate coding and splice-site variants.
Reads were aligned to hg19 using BWA [7] and duplicate
reads were marked using Picard [8] and excluded. Single
nucleotide variants and short insertions and deletions
(indels) were called using SAMtools mpileup [9] and
bcftools and quality-filtered to require a minimum 20% of
reads supporting the variant call. Variants were annotated
using Annovar [10] as well as custom scripts to select cod-
ing and splice-site variants, and to exclude common (≥1%
minor allele frequency) polymorphisms represented in the
NHLBI exome server [11], or in 435 control exomes
sequenced at the McGill University and Genome Québec
Innovation Centre. Variants within the mapped region at
16p13.3 were considered as candidates. Coverage of genes
within the region was assessed to determine the fraction of
bases in each exon with at least 5 reads covering the
position. Although average coverage was much higher,
5× was deemed sufficient to call variants within this homo-
zygous region. To determine the proportion of CCDS
exons with sufficient coverage, exons of all isoforms within
the region were counted (exons present in multiple
isoforms were counted only once) and exons with less than
99% coverage at 5×were deemed incomplete.
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500 Schemiedeleut controls, 92 Daruisleut controls, and 120
Lehrerleut controls were genotyped by a TaqMan SNP
genotyping assay for the variant. Life Technologies’ TaqMan
genotyping protocol and mix were used following standard
procedures (Forward Primer: AGAAACTTCCCACATGGT
GAGAC, Reverse Primer: ATTAGCCCTGGCACTTGGC,
Wild-type Probe: VIC-TG GCAACAATTACGGGC-mgb
(minor groove binder), Mutant Probe: FAM-ACAATTA
CAGG CAGATT-mgb).
Plasmids and site-directed mutagenesis
Wild-type (WT) THOC6 cDNA was purchased from the
Centre for Applied Genomics (Toronto). The primer sets: 5’
TTA GGA TCC ATG GAC TAC AAG GAT GAC GAT
GAC AAG GAG CGA GCT GTG CCG CTC 3’/5’ GTA
GCG GCC GC TCA GAA GGA CAG GGA GAA GGC
TCG 3’ and 5’ TTA GGA TCC ATG GAG CGA GCT
GTG CCG CTC 3’/5’ GGA GCG GCC GC TCA CTT
GTC ATC GTC ATC CTT GTA GTC GAA GGA CAG
GGA GAA GGC TCG 3’ were used to PCR amplify the full
length THOC6 cDNA in order to introduce a FLAG tag
at the N- and C-terminus, respectively and subsequently the
cDNA was subcloned into pcDNA3. Site-directed mutagen-
esis of THOC6 was performed using the QuikChange II
mutagenesis kit (Agilent). The mutated cDNA constructs
were sequenced to confirm the fidelity of the mutagenesis
reactions.
Immunostaining
HeLa cells were seeded at 2 × 105 cells/well on glass
coverslips in six-well plates and transiently transfected
with FLAG-tagged WT THOC6 or mutant THOC6 plas-
mids with lipofectamine 2000 (Invitrogen). Twenty-four
hours after the transfection, the cells were fixed in
2% paraformaldehyde and permeabilized with PBS
containing TritonX-100 (0.05%). Cells were incubated
with anti-FLAG antibody (Sigma) for 1 h followed by
incubation with Alexa 488-conjugated goat anti-mouse
IgG secondary antibody (Invitrogen). The cells were
stained with DAPI and mounted onto microscope slides.
Images were obtained with a Nikon Eclipse TE2000-E
system controlled and processed by EZ-C1 3.50 (Nikon)
software. Two replicates and a chi-square test were
performed on each replicate.
siRNA transfection
Human THOC6-specific and non-targeting control
siRNAs were purchased from Dharmacon. HeLa cells
were plated at a density of 2 × 105 cells/well on a coverslip
in a six-well plate, 24 h prior to transfections. Cells were
transfected with 100 nM of THOC6-specific or non-
targeting scramble siRNA with Lipofectamine RNAiMAX
(Invitrogen) and cultured for 48 h.TUNEL staining
TUNEL staining was performed using the in situ cell
death detection kit, TMR red (Roche), following the
manufacturer’s protocol. Two replicates and a chi-square
test were performed on each replicate.Zebrafish whole-mount in situ hybridization
Whole-mount in situ hybridization was performed on
embryos at 24, 48, and 72 h post fertilization (hpf ) as
described previously [12]. Briefly, full-length cDNA of
zebrafish thoc6 was obtained from Open Biosystems
(EDR5649-100965848). The cDNA was cloned into
pGEM-T vector (Promega) and used as a template for
in vitro synthesis of an antisense mRNA probe. Embryos
were fixed in 4% paraformaldehyde in PBS, hybridi-
zed with DIG-labeled riboprobes at 65°C, and followed
by incubation with anti-DIG antibody conjugated with
alkaline phosphatase (AP) (Roche). NBT and BICP were
used as the substrates of AP to generate the purple
coloration.Results and discussion
Identification of THOC6 as candidate gene for ID
Prior to the availability of whole-exome sequencing, the cod-
ing regions of 97 out of the 173 genes within the mapped re-
gion (NCBI build 36.3, including hypothetical genes and
pseudogenes) were Sanger sequenced in a patient and par-
ent. These genes were chosen based on expression or func-
tion indicating a potential role in neurodevelopment; genes
associated with dissimilar disorders or unrelated functions
were excluded from sequencing. A potential disease-causing
missense mutation was identified in THOC6 (fSAP35),
c.136G>A (p.Gly46Arg) (RefSeq NM_024339.3) (Figure 1A).
Sanger sequencing confirmed the presence of this potential
mutation in the homozygous state in the other three
patients.
Exome sequencing was performed to determine if any
additional potentially pathogenic variants were present
in the coding sequence of genes within the critical
region. The mean exome read depth for the sample was
143×. Exome sequencing coverage was determined for
all CCDS annotated genes (hg19) within the region and
92% of exons from all isoforms were covered completely
at greater than 5×. When Sanger sequencing results
were included this increased to 96% of exons being cov-
ered. Gene coverage statistics are included in Additional
file 1: Table S1. Variants identified by exome sequencing
were filtered to exclude common (≥1% minor allele fre-
quency) polymorphisms represented in the NHLBI
exome server [11], dbSNP, or in 435 control exomes
sequenced at our center. The only rare variant in the
mapped region was the THOC6 homozygous variant
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Figure 1 Mutation of THOC6, identified in the patients with
intellectual disability. A. Sanger sequencing indicating the
mutation c.136G>A (RefSeq NM_024339.3) as homozygous in the
patient and heterozygous in the parent. B. Conservation of the
glycine residue (red boxed) at the site of the glycine to arginine
substitution in the patients.
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state in the parents of the patients and none of the six
unaffected siblings available for testing were homozy-
gous. The variant was not seen in 150 controls from the
general population. Frequency of the variant was deter-
mined in the three Hutterite leuts by Taqman genotyp-
ing. The variant was seen at a frequency of 3% in 92
Dariusleut controls and at a frequency of 2% in 120
Lehrerleut controls; no homozygous controls were iden-
tified. The variant was not seen in 500 Schmiedeleut con-
trols indicating it is likely shared only between the
Dariusleut and Lehrerleut and that additional affected in-
dividuals may exist within these communities. The glycine
at position 46 is highly conserved between species and
occurs within a relatively conserved region (Figure 1B),
suggesting that this amino acid plays an important role in
THOC6. Polyphen [13] and SIFT [14] predicted THOC6
p.Gly46Arg to be damaging.
Next, we sequenced THOC6 in a collection of 140
female patients with ID and microcephaly; a female
patient cohort was used to enrich for non X-linked ID. No
rare homozygous or compound heterozygous variants
considered likely to be disease-causing were identified.
THOC6 is a part of the THO complex which is involved
in coordinating mRNA processing with export. In
humans, this complex is comprised of THOC1, THOC2,
THOC5, THOC6, and THOC7 [15]. The THO complex
components also interact with UAP56, ALY, and TEX
forming the larger TREX complex (transcription export
complex) [15-17]. In yeast, this complex was found to
have a role in coupling transcription and polyadenylation
to mRNA export with mutants showing defects in tran-
scription, polyadenylation, nuclear accumulation of poly
(A) RNA, the formation of heavy chromatin, andaccumulation of stalled nuclear pore components [17-19].
The necessity of the THO complex for export of individ-
ual transcripts in yeast has been linked to genes with
strong promoters and rapid transcription rates [20,21].
Initial studies in human cell lines found THOC1 to bind
DNA and interact with RNA Polymerase II as in yeast
[22]; however, recent literature has favoured the hypoth-
esis that in metazoan organisms the THO complex cou-
ples mRNA processing with export. In metazoans, the
THO complex components have only been found bound
to processed transcripts [15] and export of transcripts to
the cytoplasm by THO was determined to be both cap
and splicing dependent [23].
Impaired cellular localization of mutant THOC6 p.Gly46Arg
Members of the THO complex including THOC1,
THOC2, THOC5, and THOC7 have been found to be
localized to the nucleus and to shuttle between the nu-
cleus and the cytoplasm [24-26]. Within the nucleus,
they have been found to co-localize with splicing factors
in nuclear speckle domains and function in the release
of mRNA from these domains [15,27]. We subcloned
the WT and mutant THOC6 (c.136G>A) cDNA with a
FLAG epitope at the C-terminus into pcDNA3 vector.
Immunostaining was performed with anti-FLAG anti-
body on HeLa cells transfected with the WT and mutant
constructs. The majority of cells showed a speckled nu-
clear localization of WT THOC6 protein similar to what
has been seen for THOC1 and THOC2 [15,22,28]
(Figure 2A), whereas the mutant THOC6 p.Gly46Arg
protein was confined to the cytoplasm (Figure 2B). Simi-
lar results were obtained using N-terminal FLAG tagged
proteins. The difference in localization was significant
for both the C-terminal and N-terminal FLAG tagged
protein (chi-square test) (Additional file 2: Figure S1).
The absence of localization of the p.Gly46Arg mutant
protein in the nucleus suggests that the mutant protein’s
normal function may be perturbed. In HeLa cells,
knockdown of THOC2, THOC1, and THOC7 led to
polyA RNA nuclear accumulation, whereas knockdown
of THOC5, THOC6, and TEX did not [29]. Knockdown
of the THO complex in Drosophila appears to affect the
export of only a very small subset of mRNA transcripts
including the rapidly transcribed inducible HSP70 tran-
scripts [16]. Knockdown of THOC5 and THOC6 was
seen to lead to the retention of HSP70 mRNA in the nu-
cleus after heat shock [24]. Further elucidation of the
role of THOC6 in mRNA export will provide important
insights into the pathophysiology of this disorder.
Depletion of THOC6 increases apoptosis in mammalian cells
Apoptosis occurs during brain development and is
highly regulated; animal models and human disorders





Figure 2 Cellular localization of transfected WT and p.Gly46Arg THOC6. Left panels, HeLa cells were transiently transfected with FLAG-tagged
WT THOC6 (A) or THOC6 p. G46R (B). Green fluorescence (Alexa Fluor 488) indicates the position of the FLAG-tagged THOC6 proteins within the cell.
Middle panels, DAPI staining indicates the position of the nuclei. Right panels, merged DAPI and THOC6 images shows nuclear localization of WT THOC6
protein (A) whereas, the mutant THOC6 p.G46R protein was confined to the cytoplasm (B).
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[30-32]. There has been evidence suggesting a role of
the THO complex in the survival of rapidly proliferating
cells by preventing apoptosis [33,34]. We sought to deter-
mine whether loss of THOC6 expression causes apoptosis in
a mammalian cell line. THOC6 gene-specific siRNAs were
used to knockdown THOC6 in HeLa cells. A robust
decrease in the levels of THOC6 protein in HeLa cells
transfected with THOC6 gene-specific siRNAs (Additional
file 3: Figure S2A) was observed. TUNEL staining was
performed to examine the level of apoptosis. A significantly
increased proportion of cells with positive TUNEL staining
was seen in cells transfected with THOC6 siRNAs, com-
pared to the cells transfected with a control siRNA (Figure 3
and Additional file 3: Figure S2B), indicating that loss of





Figure 3 siRNA knockdown of THOC6 leads to increased apoptosis. H
siRNA were TUNEL stained. DAPI staining indicates the position of the nucl
cells undergoing apoptosis with positive TUNEL staining (A), compared witExpression of Thoc6 in the central nervous system during
zebrafish embryonic development
Genes implicated in neurodevelopment and ID are diverse
in function and many are not limited to central nervous sys-
tem expression, but detailed expression studies of THOC6
had not yet been performed. We examined expression of
the zebrafish thoc6 ortholog during embryonic development.
Zebrafish Thoc6 shares 59% protein sequence identity with
human THOC6, and the p.Gly46 in humans is conserved in
the zebrafish sequence. In situ hybridization revealed that
thoc6 mRNA is highly expressed in the developing midbrain
and the eyes at 24 h post fertilization (hpf) and the expres-
sion becomes restricted afterwards to the posterior part of
the midbrain and the midbrain-hindbrain boundary
(Figure 4). This expression pattern implicates an important
role for THOC6 in neurodevelopment, which is of interestEL MERGED
eLa cells transfected with THOC6-specific siRNA or no-targeting control
ei. Knocking down of THOC6 resulted in an increased proportion of




Figure 4 Expression of zebrafish thoc6 in the brain. Expression of zebrafish thoc6 was assessed by whole mount in situ hybridization. Side
views of whole mount thoc6 expression observed in 24, 48 and 72 hpf WT embryos. thoc6 is highly expressed in the developing optic tectum
and the eyes at 24 hpf (A). This expression decreases at 48 (B) and 72 hpf (C) but a low level of expression is observed at the
midbrain-hindbrain boundary.
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is intellectual disability. Given the other, more variable, clin-
ical manifestations observed in the patients, it is likely that
THOC6 also has a role in the development of other systems,
particularly the heart and kidney.
Well-characterized causes of non-syndromic ID in-
clude genes encoding for synaptic proteins, neuronal
specific proteins, and those involved in neurotransmitter
release [5]. Other causes of ID are not neural specific
genes, but genes coding for proteins that participate in
defined processes known to be important for brain func-
tion such as metabolism and cell adhesion [5,35-37].
Other identified pathways include the Rho GTPases that
play a role in regulating the actin cytoskeleton [38], the
ERK/MAPK pathway that responds to growth factors
[5], and the NF-κB transcription regulation pathway
[39-41]. Genes causing microcephaly with ID include
centrosomal, cell cycle, and DNA damage repair genes
[42,43]. Other ID genes appear to function in fundamen-
tal cellular processes, yet give rise to disorders where the
predominant or only feature is ID [1,44]; this includes
genes involved in mRNA processing such as ZC3H14
[45]. THOC6, as part of a pathway involved in mRNA
export and protection against apoptosis, is best classified
with this latter group of genes implicated in fundamental
cellular processes, though in keeping with the predomin-
ant feature of this syndrome, the highest level of expres-
sion of THOC6 is in the developing brain.Conclusion
In the current study, we have shown that a mutation
resulting in THOC6 loss-of-function is associated with a
syndromic form of autosomal recessive ID in the Hutter-
ite population. The p.Gly46Arg substitution results in
protein mislocalization to the cytoplasm. Moreover, deple-
tion of THOC6 induces apoptosis in mammalian cells. In
zebrafish, thoc6 mRNA is highly expressed in the develop-
ing central nervous system during embryonic develop-
ment. Collectively, these findings indicate that THOC6
plays an important role in human neurodevelopment.
Given that THOC6 is a member of the THO complex,
mutations in other complex members may explain a por-
tion of intellectual disability.Web resources









Additional file 1: Table S1. Coverage of genes within the mapped
region by exome and Sanger sequencing. CCDS genes within the
mapped region (including multiple gene isoforms) are listed indicating
mean coverage by exome sequencing, percentage of bases covered
greater than 5× by exome sequencing, and whether the gene was
Sanger sequenced.
Additional file 2: Figure S1. THOC6 p.Gly46Arg mutation leads to
statistically significant localization change compared to WT in transfected
cells. Cells were classified into categories based on predominant area of
THOC6 localization: nuclear localization, cytoplasmic localization, and
presence in both the nucleus and cytoplasm. Sample sizes were WT C-FLAG
n = 216, p.G46R C-FLAG n = 206, WT N-FLAG n = 272, p.G46R N-FLAG
n = 242, and the Chi-Square test indicated a significant difference (p < 0.0001).
Additional file 3: Figure S2. siRNA knockdown of THOC6 leads to
statistically significant increase in apoptosis in HeLa cells. A. A robust
decrease in the levels of THOC6 protein in HeLa cells transfected with
THOC6-specific siRNAs was seen. B. Comparison of apoptosis between
control siRNA and THOC6 siRNA transfected cells. Cells that were positive
for apoptosis based on TUNEL staining were counted (n = 2500). 5.7% of
the THOC6 siRNA transfected cells were TUNEL positive compared to
0.7% of cells transfected with control siRNA. The Chi-Square test
indicated this to be a significant increase (p < 0.0001).
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